TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014
TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
